Authors
Latest:
Regulatory Deharmonization: How Brexit May Effect the Medical Products Industry, Public HealthHow changes related to Brexit may influence regulatory, research, and economic perspectives, as well as human health.
Latest:
OTC, Prescription Drug Abuse Increasing Among AdolescentsNeighborhood pharmacists can provide support and information.
Latest:
Do Units and Costs of Comparable Insulins Differ by Manufacturer?Patient characteristics and product mix play an important role in determining the overall use and costs of comparable insulins across different manufacturers.
Latest:
Managing Schizophrenia: The Role of Pharmacies in Providing Continuing CareAs providers of long-acting treatment injections, pharmacists can positively impact medication adherence.
Latest:
Implications of the BRIDGE Trial: Should We Forgo Perioperative Anticoagulation?Atrial fibrillation is characterized by abnormal impulse formations that cause the heart to beat irregularly.
Latest:
The Unintended Side Effects of the Specialty Pharmacy Service ModelThe evolution of specialty pharmacy has raised the stakes for the services that patients expect during treatment.
Latest:
Health-System Perspectives on Oncology Market Access in 2018There is an ongoing shift toward many cancer types being treated as maintenance diseases, which places a significant financial burden not only on patients, but also payers and providers within the health care industry.
Latest:
Sliding-Scale Insulin: Time to Say Goodbye?A recent retrospective analysis showed that nearly 75% of long-term care patients with diabetes received SSI.
Latest:
Insulin Pump Therapy and Continuous Glucose MonitoringInsulin pump therapy and continuous glucose monitoring systems can be invaluable tools for patients with type 1 and type 2 diabetes.
Latest:
Cancer Patients Require Coordinated CareTreatment advances have made many cancers a chronic disease rather than a terminal disease. Here is how one dedicated team works to coordinate care and work with patients.
Latest:
Drivers of Change in Pharmacy Benefit ManagementExecutive-level pharmacy leaders in US managed care organizations identify how healthcare reform is driving changes in pharmacy benefit management.
Latest:
Reason and Impact of Patient Switching Within the Specialty Pharmacy MarketSpecialty pharmacy switching is a growing concern for providers and patients.
Latest:
Make Drug Disposal as Common as Seat BeltsIncluding medication disposal methods with prescriptions could reduce opioid diversion and childhood poisonings.
Latest:
The Impact of Abuse Deterrent Technologies on Prescription Opioid TrendsThe authors examined trends in the utilization of prescription opioid medication following introduction of abuse deterrent technology for Oxycontin.
Latest:
FDA Bars Generic Version of OxyContinThe FDA will not approve generic forms of OxyContin that lack abuse-resistant features-and OxyContin's manufacturer will be able to state that the drug has tamper-resistant properties.
Latest:
Counseling Patients with HIV/AIDSIt is prudent for pharmacists to stay current with these therapies and prevention strategies, as they are well-positioned to educate and support patients in their illness.
Latest:
HIV Cure Called 'Major Scientific Priority'Researchers continue pursuit of vaccine that will lead to HIV cure.
Latest:
Cost Implications of Early Treatment Initiation Among Patients With Newly Diagnosed FibromyalgiaInitiation of treatment with guideline-recommended medications within 60 days of fibromyalgia diagnosis was associated with immediate annual healthcare cost savings.
Latest:
Lung Cancer: Copayments and Behavior Following Erlotinib Formulary Tier ChangeMoving erlotinib from formulary tier 3 to tier 2 resulted in lower copayments and higher treatment persistence among lung cancer patients.
Latest:
CMS Revisiting Coverage Policies for Aprepitant and AmyvidThe specialty pharmacy community should remain alert in the coming months as the MEDCAC receives public comments and considers the future of Medicare coverage for 2 major therapies. The MEDCAC decision can have far-reaching impact on patient access.
Latest:
Comparative Effectiveness of TNF Blockers in Rheumatoid Arthritis PatientsAmong rheumatoid arthritis patients newly treated with adalimumab, etanercept, or infliximab, lower dose escalation rates and costs were seen with etanercept.
Latest:
Specialty Pharmacy Access to Medical Records for Patients: How it Affects CareSpecialty pharmacies dispensing erythropoiesis-stimulating agents can improve outcomes by effectively monitoring patients.
Latest:
New Compounds Protect Against Nervous System Structural Damage from Multiple SclerosisNewly characterized compounds found to block inflammation and nerve cell damage.
Latest:
Take Note: Vitamin B12 Has a Reputation in the Singing CommunityLaryngologists are unsure that vitamin B12 therapy provides any benefit and would not prescribe it.
Latest:
Cost Impact of Switching From Metoprolol to Nebivolol for HypertensionA large single-payer administrative claims database was used to assess the economic impact of switching from metoprolol to nebivolol for the treatment of hypertension.
Latest:
The Expanding Role of New Medications in the Treatment of Type 2 Diabetes MellitusWe examined the prevalence of use and cost impact of DPP-4 inhibitors and GLP-1 receptor agonists in people with diabetes.
